based on 9 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 9 analysts offering long term price targets for ERIS Lifesciences Ltd. An average target of ₹1510.33
Source: S&P Global Market Intelligence
ERIS Lifesciences Ltd price forecast by 9 analysts
Upside of17.07%
High
₹1680
Target
₹1510.33
Low
₹1230
ERIS Lifesciences Ltd target price ₹1510.33, a slight upside of 17.07% compared to current price of ₹1290.15. According to 9 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
ERIS Lifesciences Ltd revenue growth forecast
Expected growth rate Q1, FY2027:88.56%
Forecast
Actual
Including amortisation and stock based compensations
ERIS Lifesciences Ltd EPS growth forecast
EPS estimate Q1, FY2027:85.84%
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -7.14 % |
3 Month Return | -4.1 % |
1 Year Return | + 44.41 % |
Market Stats | |
Previous Close | ₹1,300.25 |
Open | ₹1,300.50 |
Volume | 43.09K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹17,700.21Cr |
P/E Ratio | 50.38 |
PEG Ratio | -18.39 |
Market Cap | ₹17,700.21 Cr |
P/B Ratio | 4.53 |
EPS | 29.19 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 12.63 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹17,700.21 Cr | 31.01% | 0.75 | ₹397 Cr | ₹2,056 Cr | |
NA | ₹10.17 Cr | 94.34% | 0.88 | NA | NA | |
NA | ₹261.26 Cr | 97.58% | 0.52 | ₹16 Cr | ₹108 Cr | |
NA | ₹122.53 Cr | 40.58% | 0.51 | NA | NA | |
NA | ₹14,909.73 Cr | -1.26% | 0.73 | ₹82 Cr | ₹1,465 Cr |
Organisation | ERIS Lifesciences Ltd |
Headquarters | Ahmedabad |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for ERIS Lifesciences Ltd
Eris Lifesciences Shows Potential for Bullish Revival - 14 Jan, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 6 months, ERIS stock has moved up by 23.0%
MF Holding Up
Mutual Funds have increased holdings from 14.52% to 17.03% in Sep 2024 quarter
Revenue Rich
Revenue is up for the last 4 quarters, 490.49 Cr → 745.72 Cr (in ₹), with an average increase of 12.7% per quarter
Retail Holding Up
Retail Investor have increased holdings from 14.30% to 18.47% in Sep 2024 quarter
Profit Spike
Netprofit is up for the last 3 quarters, 70.96 Cr → 91.59 Cr (in ₹), with an average increase of 11.9% per quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 103.2% return, outperforming this stock by 35.1%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 46.6% return, outperforming this stock by 10.9%
Promoter Holding Down
Promoters have decreased holdings from 54.88% to 54.87% in Sep 2024 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 14.59% to 8.01% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 54.87% | ||
Foreign Institutions | 8.01% | ||
Mutual Funds | 17.03% | 17.28 | |
Retail Investors | 18.47% | 29.19 | |
Others | 1.61% |
ERIS Lifesciences Ltd in the last 5 years
Lowest (16.77x)
September 9, 2019
Today (50.38x)
January 17, 2025
Industry (54.95x)
January 17, 2025
Highest (59.46x)
December 11, 2024
ERIS Lifesciences Ltd’s net profit fell -25.8% since last year same period to ₹91.59Cr in the Q2 2024-2025. On a quarterly growth basis, ERIS Lifesciences Ltd has generated 10.11% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending June 2022, ERIS Lifesciences Ltd has declared dividend of ₹7.35 - translating a dividend yield of 0.57%.
Read More about DividendsBearish
Neutral
Bullish
ERIS Lifesciences Ltd is currently in a Bearish trading position according to technical analysis indicators.
ERIS Lifesciences Ltd share price today stands at ₹1290.15, Open. ₹1300.5 ; Previous Close. ₹1300.25 ; High. ₹1308.45 ; Low. ₹1280.45 ; 52 Week High. ₹1593.9 ; 52 Week Low: ₹809.15.
ERIS Lifesciences Ltd is listed on NSE
ERIS Lifesciences Ltd is listed on BSE
PE Ratio of ERIS Lifesciences Ltd is 50.38
PE ratio = ERIS Lifesciences Ltd Market price per share / ERIS Lifesciences Ltd Earnings per share
Today’s traded volume of ERIS Lifesciences Ltd(ERIS) is 43.09K.
Today’s market capitalisation of ERIS Lifesciences Ltd(ERIS) is ₹17700.21Cr.
ERIS Lifesciences Ltd(ERIS | Price |
---|---|
52 Week High | ₹1593.9 |
52 Week Low | ₹809.15 |
ERIS Lifesciences Ltd(ERIS) share price is ₹1290.15. It is down -19.06% from its 52 Week High price of ₹1593.9
ERIS Lifesciences Ltd(ERIS) share price is ₹1290.15. It is up 59.45% from its 52 Week Low price of ₹809.15
ERIS Lifesciences Ltd(ERIS | Returns |
---|---|
1 Day Returns | -10.1% |
1 Month Returns | -7.14% |
3 Month Returns | -4.1% |
1 Year Returns | 44.41% |